Lactose
- Generic Name
- Lactose
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C12H22O11
- CAS Number
- 63-42-3
- Unique Ingredient Identifier
- 3SY5LH9PMK
- Background
A disaccharide of glucose and galactose in human and cow milk. It is used in pharmacy for tablets, in medicine as a nutrient, and in industry.
- Indication
Not Available
- Associated Conditions
- Asthma, Chronic Obstructive Pulmonary Disease (COPD), Hypothyroidism, Opioid Dependence, Thyroid Cancer
- Associated Therapies
- Maintenance treatment, opioids, Opioid Detoxification
The Effectiveness of Gabapentin for Post-operative Pain Following Cesarean Section
- Conditions
- Interventions
- First Posted Date
- 2010-03-29
- Last Posted Date
- 2011-02-23
- Target Recruit Count
- 126
- Registration Number
- NCT01094925
- Locations
- 🇨🇦
Mount Sinai Hospital, Toronto, Ontario, Canada
Efficacy of L-Ornithine L-Aspartate in Acute Hepatic Encephalopathy.
- Conditions
- Interventions
- First Posted Date
- 2010-01-01
- Last Posted Date
- 2021-05-10
- Target Recruit Count
- 30
- Registration Number
- NCT01041755
- Locations
- 🇲🇽
Hospital Universitario "José Eleuterio González", Monterrey, Nuevo León, Mexico
Colchicine Treatment for Chronic Shoulder Pain Related to Calcific Tendonitis
- First Posted Date
- 2009-09-23
- Last Posted Date
- 2010-07-20
- Lead Sponsor
- Bnai Zion Medical Center
- Target Recruit Count
- 80
- Registration Number
- NCT00983177
- Locations
- 🇮🇱
Bnai Zion Medical Center, Haifa, Israel
Prophylactic Treatment of Travellers' Diarrhoea With Rifaximin
- First Posted Date
- 2009-09-17
- Last Posted Date
- 2013-11-08
- Lead Sponsor
- Dr. Philipp Zanger, MD MSc DTM
- Target Recruit Count
- 258
- Registration Number
- NCT00979056
- Locations
- 🇩🇪
Institute of Tropical Medicine, University Hospital of Tübingen, Tübingen, Germany
Double-blind, Placebo-controlled Study of BGC20-1531 in Migraine
- First Posted Date
- 2009-04-28
- Last Posted Date
- 2022-06-03
- Lead Sponsor
- Boston Scientific Corporation
- Registration Number
- NCT00888680
- Locations
- 🇩🇰
Danish Headache Center, Glostrup, Denmark
🇬🇧The City of London Migraine Clinic, London, United Kingdom
🇳🇴Norwegian National Headache Centre, Trondheim, Norway
DAS181 Single Dose Escalation Study in Healthy Adults
- First Posted Date
- 2009-04-06
- Last Posted Date
- 2019-08-02
- Lead Sponsor
- Ansun Biopharma, Inc.
- Target Recruit Count
- 45
- Registration Number
- NCT00876161
- Locations
- 🇺🇸
Quintiles Phase One Services, Overland Park, Kansas, United States
Prospective Evaluation of the Efficacy of Budesonide/Formoterol in Bronchiolitis Obliterans in AHSCT
- Conditions
- Interventions
- First Posted Date
- 2008-02-27
- Last Posted Date
- 2013-05-06
- Lead Sponsor
- Assistance Publique - Hôpitaux de Paris
- Target Recruit Count
- 32
- Registration Number
- NCT00624754
- Locations
- 🇫🇷
Hôpital Saint Louis, Paris, France
Pharmacological Modulations of Allergen-Specific Immunotherapy
- Conditions
- Interventions
- First Posted Date
- 2007-07-20
- Last Posted Date
- 2008-04-11
- Lead Sponsor
- Medical University of Lodz
- Target Recruit Count
- 85
- Registration Number
- NCT00504946
- Locations
- 🇵🇱
Department of Pediatrics and Allergy, Medical University of Lodz Lodz, Poland, Lodz, Poland
St. John's Wort in the Treatment of Raynaud's Phenomenon
- First Posted Date
- 2006-07-12
- Last Posted Date
- 2009-07-14
- Lead Sponsor
- Lawson Health Research Institute
- Target Recruit Count
- 20
- Registration Number
- NCT00351117
- Locations
- 🇨🇦
Rheumatology Clinic, St. Joseph's Health Care, London, Ontario, Canada
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.